Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.
American journal of obstetrics and gynecology
pharmacodynamic; pharmacokinetic; postpartum hemorrhage; prevention; tranexamic acid
Funding text #1 The project was funded by the National Institutes of Health (NIH) (K23HL141640 and KL2TR001877/UL1TR001876 to H.K.A., R61HL141791 to A.S.W., and T32HD087969 to J.V.D.A.). Of note, this publication was supported by award numbers UL1TR001876 and KL2TR001877 from the NIH National Center for Advancing Translational Sciences .
Ahmadzia, H. K., Luban, N. L., Li, S., Guo, D., Miszta, A., Gobburu, J., Berger, J. S., James, A., Wolberg, A., & van den Anker, J. (2020). Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women.. American journal of obstetrics and gynecology, (). http://dx.doi.org/10.1016/j.ajog.2020.11.035